FiercePharma

- Reduction of disease activity, prevention of further joint damage and preservation of physical function were the three goals evaluated

ABBOTT PARK, Ill., Nov. 12, 2012 /PRNewswire/ -- Abbott today announced results from a post-hoc analysis of HUMIRA ® (adalimumab) data in early and long-standing moderate-to-severe rheumatoid ...
Seeking Alpha

RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed ...

NORTH CHICAGO, Ill., Oct. 20, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study evaluating the efficacy and safety of ...
FiercePharma

Abbott Announces Three-Year Long-Term Data Evaluating Efficacy with HUMIRA® (Adalimumab) For Patients with Moderately to Severely Active Ulcerative Colitis

ABBOTT PARK, Ill., Oct. 22, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) today announced results from an analysis of three-year long-term data from an ongoing open-label extension of the HUMIRA® ...
Drug Store News

FDA grants interchangeability designation for Humira biosimilar to Samsung Bioepis, Organon

Samsung Bioepis and Organon shared that the Food and Drug Administration has designated the Hadlima (adalimumab-bwwd) high- and low-concentration (40 mg/0.4 ml, 40 mg/0.8 ml) autoinjectors and ...
Healthline

Humira Interactions: Alcohol, Medications, and Others

Humira (adalimumab) has potential interactions with several other drugs. For example, taking prednisone with Humira can increase the risk of side effects from both drugs. Humira may also interact with ...
Seeking Alpha

Alvotech/Teva win FDA approval for Humira biosimilar

Alvotech (NASDAQ:ALVO) and partner Teva Pharmaceuticals (NYSE:TEVA) announced Friday the U.S. Food and Drug Administration (FDA) approval for their arthritis injection, Simlandi (adalimumab-ryvk).
Healio

US Veterans Affairs to replace Humira with biosimilar on national formulary

Please provide your email address to receive an email when new articles are posted on . Hadlima was approved as a biosimilar to Humira in 2019. The drug is available in a pre-filled syringe or a ...
Medscape

FDA Approves Yuflyma as Ninth Adalimumab Biosimilar

The US Food and Drug Administration (FDA) has approved the biosimilar adalimumab-aaty (Yuflyma) in a citrate-free, high-concentration formulation, the manufacturer, Celltrion USA, announced today. It ...
Healio

Drug costs and nocebo risks: Navigating the Humira ‘biosimilar boom’ 1 year later

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The first Humira biosimilar hit the U.S. market a little ...
Monthly Prescribing Reference

FDA Approves Simlandi, a Citrate-Free, High-Concentration, Interchangeable Biosimilar to Humira

Credit: Teva. Simlandi is an interchangeable biosimilar and can be substituted for the reference product without requiring a prescription change. The Food and Drug Administration (FDA) has approved ...
Seattle Times

Humira, the world’s No. 1 drug, finally faces low-cost competitors

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor. Alternatives to the world’s ...